FDA committee considers neuroAD therapy system to treat Alzheimers disease

FDA committee considers neuroAD therapy system to treat Alzheimer’s disease

15:26 EDT 25 Mar 2019 | Compelo Medical Devices

Neuronix said that the neuroAD Therapy System is presently approved and is being sold across Europe, Australia and Israel. In the US, though it still remains as investigational

FDA committee considers neuroAD therapy system to treat Alzheimers disease

FDA committee considers neuroAD therapy system to treat Alzheimer’s disease

More From BioPortfolio on "FDA committee considers neuroAD therapy system to treat Alzheimer’s disease"